Leerink Partnrs Predicts Stronger Earnings for Henry Schein

Henry Schein, Inc. (NASDAQ:HSIC) – Equities research analysts at Leerink Partnrs lifted their FY2024 earnings estimates for shares of Henry Schein in a report released on Monday, October 14th. Leerink Partnrs analyst M. Cherny now anticipates that the company will post earnings per share of $4.76 for the year, up from their prior estimate of $4.75. The consensus estimate for Henry Schein’s current full-year earnings is $4.74 per share. Leerink Partnrs also issued estimates for Henry Schein’s Q4 2024 earnings at $1.25 EPS, FY2025 earnings at $5.31 EPS, FY2026 earnings at $5.87 EPS and FY2027 earnings at $6.44 EPS.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, August 6th. The company reported $1.23 earnings per share for the quarter, beating analysts’ consensus estimates of $1.22 by $0.01. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The company had revenue of $3.10 billion for the quarter, compared to the consensus estimate of $3.27 billion. During the same period last year, the company posted $1.31 EPS. The firm’s quarterly revenue was up .0% compared to the same quarter last year.

A number of other equities research analysts also recently weighed in on HSIC. JPMorgan Chase & Co. reduced their price target on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a research note on Monday, August 12th. Baird R W upgraded shares of Henry Schein from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 22nd. Evercore ISI lifted their target price on shares of Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 8th. Barrington Research reiterated an “outperform” rating and set a $82.00 target price on shares of Henry Schein in a research report on Friday, September 20th. Finally, UBS Group cut their target price on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating on the stock in a research report on Wednesday, August 7th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating, five have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, Henry Schein has a consensus rating of “Hold” and a consensus target price of $77.50.

Henry Schein Trading Down 0.1 %

HSIC opened at $71.67 on Thursday. The company’s 50 day moving average is $70.26 and its 200-day moving average is $69.90. Henry Schein has a 1-year low of $60.01 and a 1-year high of $82.63. The company has a current ratio of 1.55, a quick ratio of 0.90 and a debt-to-equity ratio of 0.46. The company has a market cap of $9.18 billion, a P/E ratio of 24.21, a PEG ratio of 1.98 and a beta of 0.86.

Hedge Funds Weigh In On Henry Schein

A number of institutional investors and hedge funds have recently made changes to their positions in HSIC. Vanguard Group Inc. lifted its position in Henry Schein by 1.7% in the 1st quarter. Vanguard Group Inc. now owns 15,432,001 shares of the company’s stock valued at $1,165,425,000 after acquiring an additional 260,537 shares in the last quarter. American Century Companies Inc. lifted its position in Henry Schein by 3.1% in the 2nd quarter. American Century Companies Inc. now owns 5,484,286 shares of the company’s stock valued at $351,543,000 after acquiring an additional 162,477 shares in the last quarter. Swedbank AB bought a new position in Henry Schein in the 1st quarter valued at about $215,998,000. Nuance Investments LLC lifted its position in Henry Schein by 6.2% in the 2nd quarter. Nuance Investments LLC now owns 1,863,333 shares of the company’s stock valued at $119,440,000 after acquiring an additional 108,143 shares in the last quarter. Finally, Burgundy Asset Management Ltd. lifted its position in Henry Schein by 1.0% in the 2nd quarter. Burgundy Asset Management Ltd. now owns 1,640,379 shares of the company’s stock valued at $105,148,000 after acquiring an additional 16,476 shares in the last quarter. Institutional investors own 96.62% of the company’s stock.

Insider Activity at Henry Schein

In other news, SVP Lorelei Mcglynn sold 21,035 shares of the stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the transaction, the senior vice president now owns 71,833 shares of the company’s stock, valued at $4,978,026.90. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.14% of the stock is owned by corporate insiders.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.